StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Hikma Pharmaceuticals PLC
LSE:HIK.L
Sector
Location
Market Cap
USD 5.96 B
Share Price
USD 26.95
Avg Daily Volume
494,127
Change (1 day)
0.70%
Change (1 year)
12.00%
Change (YTD)
8.08%
Hikma Pharmaceuticals PLC Return on Equity (ROE) for the year ending December 31, 2024: 15.54%
Hikma Pharmaceuticals PLC Return on Equity (ROE) is 15.54% for the year ending December 31, 2024, a 79.79% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.
-
Hikma Pharmaceuticals PLC Return on Equity (ROE) for the year ending December 31, 2023 was 8.64%, a -1.83% change year over year.
-
Hikma Pharmaceuticals PLC Return on Equity (ROE) for the year ending December 31, 2022 was 8.81%, a -48.69% change year over year.
-
Hikma Pharmaceuticals PLC Return on Equity (ROE) for the year ending December 31, 2021 was 17.16%, a -14.98% change year over year.
-
Hikma Pharmaceuticals PLC Return on Equity (ROE) for the year ending December 31, 2020 was 20.19%, a -12.06% change year over year.
Competitors
Johnson & Johnson
USD 163.70
JNJ
+0.72
0.44%
Zhangzhou Pientzehuang Pharmaceutical., Ltd
USD 27.71
600436.SS
+0.12
0.42%
Yunnan Baiyao Group Co.,Ltd
USD 7.83
000538.SZ
+0.00
0.03%
Huadong Medicine Co., Ltd
USD 6.24
000963.SZ
+0.12
1.97%
Alibaba Health Information Technology Limited
USD 0.60
0241.HK
+0.01
1.31%
Ypsomed Holding AG
USD 533.01
YPSN.SW
+5.37
1.02%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
USD 2.30
0874.HK
+0.01
0.24%
Galenica AG
USD 111.59
GALE.SW
+0.72
0.65%
Nahdi Medical Company
USD 34.79
4164.SR
+0.18
0.53%
Dong-E-E-Jiao Co.,Ltd.
USD 6.94
000423.SZ
+0.03
0.50%
PT Kalbe Farma Tbk.
USD 0.09
KLBF.JK
+0.00
0.37%
Ajanta Pharma Limited
USD 32.18
AJANTPHARM.NS
-0.19
-0.58%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
USD 5.08
600329.SS
+0.10
1.94%
Aspen Pharmacare Holdings Limited
USD 6.42
APN.JO
+0.05
0.71%
Suzuken Co., Ltd.
USD 36.99
9987.T
+0.02
0.06%
Hanmi Science Co., Ltd.
USD 35.64
008930.KS
+1.19
3.46%
Hisamitsu Pharmaceutical Co., Inc.
USD 27.11
4530.T
+0.07
0.26%
Tsumura & Co.
USD 24.40
4540.T
-0.01
-0.03%
China National Accord Medicines Corporation Ltd.
USD 3.52
000028.SZ
+0.02
0.45%
Key Data
| Date | Return on Equity (ROE) | Return on Assets (ROA) | Revenue Per Share | Free Cash Flow Per Share |
|---|
Competitors
Johnson & Johnson
USD 163.70
JNJ
+0.72
0.44%
Zhangzhou Pientzehuang Pharmaceutical., Ltd
USD 27.71
600436.SS
+0.12
0.42%
Yunnan Baiyao Group Co.,Ltd
USD 7.83
000538.SZ
+0.00
0.03%
Huadong Medicine Co., Ltd
USD 6.24
000963.SZ
+0.12
1.97%
Alibaba Health Information Technology Limited
USD 0.60
0241.HK
+0.01
1.31%
Ypsomed Holding AG
USD 533.01
YPSN.SW
+5.37
1.02%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
USD 2.30
0874.HK
+0.01
0.24%
Galenica AG
USD 111.59
GALE.SW
+0.72
0.65%
Nahdi Medical Company
USD 34.79
4164.SR
+0.18
0.53%
Dong-E-E-Jiao Co.,Ltd.
USD 6.94
000423.SZ
+0.03
0.50%
PT Kalbe Farma Tbk.
USD 0.09
KLBF.JK
+0.00
0.37%
Ajanta Pharma Limited
USD 32.18
AJANTPHARM.NS
-0.19
-0.58%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
USD 5.08
600329.SS
+0.10
1.94%
Aspen Pharmacare Holdings Limited
USD 6.42
APN.JO
+0.05
0.71%
Suzuken Co., Ltd.
USD 36.99
9987.T
+0.02
0.06%
Hanmi Science Co., Ltd.
USD 35.64
008930.KS
+1.19
3.46%
Hisamitsu Pharmaceutical Co., Inc.
USD 27.11
4530.T
+0.07
0.26%
Tsumura & Co.
USD 24.40
4540.T
-0.01
-0.03%
China National Accord Medicines Corporation Ltd.
USD 3.52
000028.SZ
+0.02
0.45%